Clostridioides Difficile Infections (cdi) - Infectious Diseases

Relevant Publications

Insoluble polysaccharides produced in plant cell cultures protect from Clostridioides difficile colitis.

Issue Release: 2024

The ESCMID Study Group for Clostridioides difficile: History, Role, and Perspectives.

Issue Release: 2024

A Multimodal Intervention to Reduce C. difficile Infections and Stool Testing.

Issue Release: 2024

The burden of Clostridioides difficile infections in South-East Asia and the Western Pacific: A narrative review.

Issue Release: 2024

The anti-inflammatory and anti-apoptotic effects of Achillea millefolium L. extracts on Clostridioides difficile ribotype 001 in human intestinal epithelial cells.

Issue Release: 2024

Organizational and Infrastructural Risk Factors for Healthcare-associated Clostridioides difficile Infections or Methicillin-resistant Staphylococcus aureus in Hospitals.

Issue Release: 2024

Comparative effectiveness of vancomycin and metronidazole on event-free survival after initial infection in patients with Clostridioides difficile - a German multicentre cohort study (IBIS).

Issue Release: 2024

Toxin inhibition: Examining tetracyclines, clindamycin, and linezolid.

Issue Release: 2024

Infection Control Measure Performance in Long-Term Care Hospitals and Their Relationship to Joint Commission Accreditation.

Issue Release: 2024

Ribotypes and New Virulent Strains Across Europe.

Issue Release: 2024

Antibiotic Resistances of Clostridioides difficile.

Issue Release: 2024

Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015-2019: The RECUR England study.

Issue Release: 2024

Clostridioides difficile infections, recurrences, and clinical outcomes in real-world settings from 2015-2019: The RECUR England study.

Issue Release: 2024

Clinical outcomes and treatment necessity in patients with toxin-negative Clostridioides difficile stool samples.

Issue Release: 2024

Occurrence and trends of Clostridioides difficile infections in hospitalized patients: a prospective multicentre cohort study in six German university hospitals, 2016-2020.

Issue Release: 2024

Deep learning-based prediction of Clostridioides difficile infection caused by antibiotics using longitudinal electronic health records.

Issue Release: 2024

The 3 Ds: Depression, Dysbiosis, and Clostridiodes difficile.

Issue Release: 2024

Efficacy of prophylactic antibiotics in the adjuvant treatment of alcohol-related liver disease (ALD): a Systematic review and meta-analysis: Prophylactic antibiotics in ALD.

Issue Release: 2024

Rational Design of Live Biotherapeutic Products for the Prevention of Clostridioides difficile Infection.

Issue Release: 2024

Fecal Microbiota Transplantation as Emerging Treatment in European Countries 2.0.

Issue Release: 2024

What is the National Institutes of Health (NIH)?

What Role Do Metabolic Pathways Play in Antibiotic Resistance?

How Does Transmission Occur?

What are the Challenges in HIV Treatment?

How Can Individuals Contribute to One Health?

What is the Prognosis for Cervical Cancer?

How Can Pregnant Women Reduce the Risk of Infections?

What are the Implications of Genomics for Treatment?

How Do Bacteria Cause Disease?

How Can HIV/AIDS Be Prevented?

Partnered Content Networks

Relevant Topics